New York, New York, United States The main department of described VC is located in the New York. The fund was located in North America if to be more exact in United States.
The overall number of key employees were 1.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Baker Brothers Advisors LLC, startups are often financed by New Leaf Venture Partners, Alta Partners, Sofinnova Investments. The meaningful sponsors for the fund in investment in the same round are Ventures West, New Leaf Venture Partners, Sofinnova Investments. In the next rounds fund is usually obtained by New Leaf Venture Partners, Redmile Group, Yasuda Enterprise Development.
The important activity for fund was in 2007. Comparing to the other companies, this Baker Brothers Advisors LLC performs on 14 percentage points more the average number of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 1 percentage points less often commits exit comparing to other organizations. The top amount of exits for fund were in 2019. The fund is constantly included in less than 2 deals per year.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Health Diagnostics. The fund has exact preference in some founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Synageva BioPharma, diaDexus, MethylGene
Related Funds
Funds with similar focus
| Fund Name | Location |
| Biosensors | Japan, Tokyo |
| Capital Point | Israel, Tel Aviv, Tel Aviv District |
| Emerging Technology Partners | California, San Francisco, United States |
| Forbes Family Trust | New York, New York, United States |
| Fountainhead Investment Partners | - |
| Global Millennial Capital | Dubai, United Arab Emirates |
| Janchor Partners | China, Hong Kong, Hong Kong Island |
| Kingdom Holding Company | Ar Riyad, Riyadh, Saudi Arabia |
| Kington Capital | China, Jiangsu, Suzhou |
| Musketeer Capital | Haverford, Pennsylvania, United States |
| Senshu Ikeda Holdings | Japan, Osaka, Osaka Prefecture |
| Shaw Communications | Alberta, Calgary, Canada |
| Strategic Equities | - |
| Torstar Corporation | Canada, Ontario, Toronto |
| V8 Capital Partners | Ebène, Mauritius, Plaines Wilhems |
| Venvest Capital | California, Santa Monica, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
IGM Biosciences | $102M | 08 Jul 2019 | Mountain View, California, United States | ||
Cabaletta Bio | $50M | 03 Jan 2019 | Philadelphia, Pennsylvania, United States | ||
Cabaletta Bio | $38M | 08 Nov 2018 | Philadelphia, Pennsylvania, United States | ||
Kiniksa Pharmaceuticals | $200M | 01 Feb 2018 | Bermuda, Devonshire, Bermuda | ||
Hookipa Pharma | $60M | 11 Dec 2017 | Vienna, Austria | ||
| $40M | 01 Mar 2017 | Bermuda | |||
| $80M | 01 Oct 2015 | Bermuda | |||
Principia Biopharma | $15M | 10 Aug 2015 | - | ||
Aquinox Pharmaceuticals | $18M | 03 Apr 2013 | Vancouver, British Columbia, Canada |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
IGM Biosciences | $102M | 08 Jul 2019 | Mountain View, California, United States | ||
Cabaletta Bio | $50M | 03 Jan 2019 | Philadelphia, Pennsylvania, United States | ||
Cabaletta Bio | $38M | 08 Nov 2018 | Philadelphia, Pennsylvania, United States | ||
Kiniksa Pharmaceuticals | $200M | 01 Feb 2018 | Bermuda, Devonshire, Bermuda | ||
Hookipa Pharma | $60M | 11 Dec 2017 | Vienna, Austria | ||
| $40M | 01 Mar 2017 | Bermuda | |||
| $80M | 01 Oct 2015 | Bermuda | |||
Principia Biopharma | $15M | 10 Aug 2015 | - | ||
Aquinox Pharmaceuticals | $18M | 03 Apr 2013 | Vancouver, British Columbia, Canada |
